Hamid Sharif Nia1, Saeed Pahlevan Sharif2, Rebecca H Lehto3, Christopher Boyle4, Ameneh Yaghoobzadeh5, Omolhoda Kaveh6, Amir Hossein Goudarzian7. 1. Department of Medical-Surgical Nursing, School of Nursing and Midwifery Amol, Mazandaran University of Medical Sciences, Sari, Iran. 2. Department of Taylor's Business School, Taylor's University Malaysia, Subang Jaya, Malaysia. 3. Department of Nursing, Michigan State University College of Nursing, Michigan, USA. 4. Graduate School of Education. University of Exeter, UK. 5. Master in Geriatric Nursing, Tehran University of Medical Sciences, Tehran. 6. PhD Student of Nursing, Iran University of Medical Science, Tehran, Iran. 7. BSc of Nursing, Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract
OBJECTIVE: The surfacing of thoughts and depressive affect associated with the prospect of death are prevalent among patients with advanced cancer. Because death cognitions and associated negative affect occur along an adaptive-less adaptive continuum, it is essential that valid and reliable instruments are available to measure death depression. The present study aimed to determine the psychometric properties of the Death Depression Scale among Iranian patients with advanced cancer. METHODS: About 497 cancer patients completed a Persian version of the 21-item Death Depression Scale-Revised. The face, content and construct validity of the scale were ascertained. Reliability was also assessed using internal consistency, construct reliability and intra-class correlation coefficient (ICC). RESULTS: Construct validity determined one factor with an eigenvalue greater than 1. The model had a good fit (χ2 (179, N = 248) = 520.345, P < 0.001; χ2/df = 2.907, CFI = 0.916, TLI = 0.902, IFI = 0.917, SRMR = 0.049 and RMSEA = 0.088 (90% confidence interval = 0.079-0.097)) with all factors loadings greater than 0.5 and statistically significant. The internal consistency, construct reliability and ICC were greater than 0.70. Convergent validity of the scale was demonstrated. CONCLUSIONS: Findings revealed that the Persian version of the Death Depression Scale-Revised is valid and reliable, and may be used to assess and evaluate death depression in Iranian patients with advanced cancer.
OBJECTIVE: The surfacing of thoughts and depressive affect associated with the prospect of death are prevalent among patients with advanced cancer. Because death cognitions and associated negative affect occur along an adaptive-less adaptive continuum, it is essential that valid and reliable instruments are available to measure death depression. The present study aimed to determine the psychometric properties of the Death Depression Scale among Iranian patients with advanced cancer. METHODS: About 497 cancer patients completed a Persian version of the 21-item Death Depression Scale-Revised. The face, content and construct validity of the scale were ascertained. Reliability was also assessed using internal consistency, construct reliability and intra-class correlation coefficient (ICC). RESULTS: Construct validity determined one factor with an eigenvalue greater than 1. The model had a good fit (χ2 (179, N = 248) = 520.345, P < 0.001; χ2/df = 2.907, CFI = 0.916, TLI = 0.902, IFI = 0.917, SRMR = 0.049 and RMSEA = 0.088 (90% confidence interval = 0.079-0.097)) with all factors loadings greater than 0.5 and statistically significant. The internal consistency, construct reliability and ICC were greater than 0.70. Convergent validity of the scale was demonstrated. CONCLUSIONS: Findings revealed that the Persian version of the Death Depression Scale-Revised is valid and reliable, and may be used to assess and evaluate death depression in Iranian patients with advanced cancer.
Authors: Saeed Pahlevan Sharif; Rebecca H Lehto; Hamid Sharif Nia; Amir Hossein Goudarzian; Ali Akbar Haghdoost; Ameneh Yaghoobzadeh; Bahram Tahmasbi; Roghieh Nazari Journal: Support Care Cancer Date: 2018-02-15 Impact factor: 3.603
Authors: Hamid Sharif Nia; Saeed Pahlevan Sharif; Rebecca H Lehto; Kelly A Allen; Amir Hossein Goudarzian; Ameneh Yaghoobzadeh; Mohammad Ali Soleimani Journal: Iran J Psychiatry Date: 2017-07